A Review of Neoplasms with MITF/MiT Family Translocations

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2022 Feb 2

PMID 35107169

Authors

Shuanzeng Wei

Joseph R Testa

Pedram Argani

Affiliations

Soon will be listed here.

Abstract

Microphthalmia-associated transcription factor (MITF/MiT) family is a group of basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factors including TFE3 (TFEA), TFEB, TFEC and MITF. The first renal neoplasms involving MITF family translocation were renal cell carcinomas with chromosome translocations involving ASPL-TFE3/t(X;17)(p11.23;q25) or MALAT1-TFEB/t(6;11)(p21.1;q12), and now it is known as MiT family translocation RCC in 2016 WHO classification. Translocations involving MITF family genes also are found in other tumor types, such as perivascular epithelioid cell neoplasm (PEComa), Alveolar soft part sarcoma (ASPS), epithelioid hemangioendothelioma, ossifying fibromyxoid tumor (OFMT), and clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation. In this review, we summarize the features of different types of neoplasms with MITF family translocations.

Citing Articles

Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.

Perotti D, OSullivan M, Walz A, Davick J, Al-Saadi R, Benedetti D Nat Rev Urol. 2025; .

PMID: 39881003 DOI: 10.1038/s41585-024-00993-6.

Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature.

Holic L Med Oncol. 2024; 41(6):157.

PMID: 38758457 DOI: 10.1007/s12032-024-02385-7.

Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.

Yang Y, Zhao C, Wang Z, Liu F, Zhao M, Yang H Aging (Albany NY). 2024; 16(2):1696-1711.

PMID: 38261736 PMC: 10866448. DOI: 10.18632/aging.205452.

Metastatic Translocated Renal Cell Carcinoma in a Kidney Transplant Patient - a Case Report and Review of the Literature.

Klager J, Schmidinger M, Oszwald A, Wasinger G, Fajkovic H, Comperat E Int J Surg Pathol. 2023; 32(3):594-600.

PMID: 37415400 PMC: 11025305. DOI: 10.1177/10668969231185070.

MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.

Hamada T, Higashi M, Yokoyama S, Akahane T, Hisaoka M, Noguchi H BMC Cancer. 2023; 23(1):424.

PMID: 37165307 PMC: 10173563. DOI: 10.1186/s12885-023-10867-6.

References

Agaram N, Sung Y, Zhang L, Chen C, Chen H, Singer S . Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications. Am J Surg Pathol. 2015; 39(6):813-25. PMC: 4431898. DOI: 10.1097/PAS.0000000000000389. View

Antic T, Taxy J, Alikhan M, Segal J . Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion. Am J Surg Pathol. 2017; 41(11):1576-1580. DOI: 10.1097/PAS.0000000000000927. View

Antonescu C, Le Loarer F, Mosquera J, Sboner A, Zhang L, Chen C . Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013; 52(8):775-84. PMC: 4089994. DOI: 10.1002/gcc.22073. View

Argani P . MiT family translocation renal cell carcinoma. Semin Diagn Pathol. 2015; 32(2):103-13. DOI: 10.1053/j.semdp.2015.02.003. View

Argani P, Hawkins A, Griffin C, GOLDSTEIN J, Haas M, Beckwith J . A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001; 158(6):2089-96. PMC: 1891971. DOI: 10.1016/S0002-9440(10)64680-9. View

Argani P, Antonescu C, Illei P, Lui M, Timmons C, Newbury R . Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001; 159(1):179-92. PMC: 1850400. DOI: 10.1016/S0002-9440(10)61684-7. View

Argani P, Antonescu C, Couturier J, Fournet J, Sciot R, Debiec-Rychter M . PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002; 26(12):1553-66. DOI: 10.1097/00000478-200212000-00003. View

Argani P, Lui M, Couturier J, Bouvier R, Fournet J, Ladanyi M . A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003; 22(34):5374-8. DOI: 10.1038/sj.onc.1206686. View

Argani P, Lal P, Hutchinson B, Lui M, Reuter V, Ladanyi M . Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003; 27(6):750-61. DOI: 10.1097/00000478-200306000-00005. View

10.

Argani P, Lae M, Hutchinson B, Reuter V, Collins M, Perentesis J . Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005; 29(2):230-40. DOI: 10.1097/01.pas.0000146007.54092.37. View

11.

Argani P, Lae M, Ballard E, Amin M, Manivel C, Hutchinson B . Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006; 24(10):1529-34. DOI: 10.1200/JCO.2005.04.4693. View

12.

Argani P, Olgac S, Tickoo S, Goldfischer M, Moch H, Chan D . Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007; 31(8):1149-60. DOI: 10.1097/PAS.0b013e318031ffff. View

13.

Argani P, Aulmann S, Karanjawala Z, Fraser R, Ladanyi M, Rodriguez M . Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol. 2008; 33(4):609-19. DOI: 10.1097/PAS.0b013e31818fbdff. View

14.

Argani P, Hicks J, De Marzo A, Albadine R, Illei P, Ladanyi M . Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010; 34(9):1295-303. PMC: 3449149. DOI: 10.1097/PAS.0b013e3181e8ce5b. View

15.

Argani P, Aulmann S, Illei P, Netto G, Ro J, Cho H . A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010; 34(10):1395-406. DOI: 10.1097/PAS.0b013e3181f17ac0. View

16.

Argani P, Yonescu R, Morsberger L, Morris K, Netto G, Smith N . Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol. 2012; 36(10):1516-26. PMC: 4441265. DOI: 10.1097/PAS.0b013e3182613d8f. View

17.

Argani P, Zhong M, Reuter V, Fallon J, Epstein J, Netto G . TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Am J Surg Pathol. 2016; 40(6):723-37. PMC: 4864095. DOI: 10.1097/PAS.0000000000000631. View

18.

Argani P, Reuter V, Zhang L, Sung Y, Ning Y, Epstein J . TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity. Am J Surg Pathol. 2016; 40(11):1484-1495. PMC: 5069163. DOI: 10.1097/PAS.0000000000000720. View

19.

Argani P, Zhang L, Reuter V, Tickoo S, Antonescu C . RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH. Am J Surg Pathol. 2017; 41(5):655-662. PMC: 5391276. DOI: 10.1097/PAS.0000000000000835. View

20.

Argani P, Zhang L, Sung Y, White M, Miller K, Hopkins M . A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor. Genes Chromosomes Cancer. 2019; 59(1):58-63. PMC: 7057291. DOI: 10.1002/gcc.22801. View